Top

European Journal of Clinical Microbiology & Infectious Diseases

Published in:

01-10-2020 | SARS-CoV-2 | Brief Report

The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?

Authors: Eric Farfour, Philippe Lesprit, Benoit Visseaux, Tiffany Pascreau, Emilie Jolly, Nadira Houhou, Laurence Mazaux, Marianne Asso-Bonnet, Marc Vasse, on behalf of the SARS-CoV-2 Foch Hospital study group

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2020

Abstract

Several commercial assays for SARS-CoV-2 RT-PCR are available but few of them were assessed. We evaluate the Allplex 2019-nCoV (Seegene) assay using 41 nasopharyngeal samples. The rates of agreement were 92.7% and 100% with the GeneFinder COVID-19 plus (Elitech) and the diagnosis of the infectious disease specialist respectively. Four samples display a Ct < 22.0 for the E and RdRp genes while the N gene was not detected, suggesting a variability of the viral sequence. There was no cross-reactivity with other respiratory viruses. The Allplex 2019-nCoV appears as a reliable method, but additional evaluations using more samples are needed. RT-PCR assays should probably include at least 2 viral targets.

ECDC (2020) 2019-ncov situation update. https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases

Wang C, Liu Z, Chen Z, Huang X, Xu M, He T, et al (2020) The establishment of reference sequence for SARS-CoV-2 and variation analysis. J. Med. Virol [cited 2020 12];jmv.25762. https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.25762

Pan Y, Zhang D, Yang P, Poon LLM, Wang Q (2020) Viral load of SARS-CoV-2 in clinical samples. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(20)30113-4

Seegene (2020) Allplex 2019-nCoV Assay Instruction for use

Ceraolo C, Giorgi FM (2020) Genomic variance of the 2019-nCoV coronavirus. J Med Virol 92:522–528. https://doi.org/10.1002/jmv.25700CrossRefPubMedPubMedCentral

Pfefferle S, Reucher S, Nörz D, Lütgehetmann M (2020) Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system. Eurosurveillance 25:2000152. https://doi.org/10.2807/1560-7917.es.2020.25.9.2000152CrossRefPubMedCentral

Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK et al (2020) Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 1:25. https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045CrossRef

Nalla AK, Casto AM, Huang M-LW, Perchetti GA, Sampoleo R, Shrestha L, et al (2020) Comparative performance of SARS-CoV-2 detection assays using seven different primer/probe sets and one assay kit. J. Clin. Microbiol [cited 2020 18]. http://jcm.asm.org/lookup/doi/10.1128/JCM.00557-20

Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al (2020) Correlation of chest CT and RT-PCR testing in coronavirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology 26 [cited 2020 26];200642. http://www.ncbi.nlm.nih.gov/pubmed/32101510. https://doi.org/10.1148/radiol.2020200642

10.

Li D, Wang D, Dong J, Wang N, Huang H, Xu H, et al (2020) False-negative results of real-time reverse-transcriptase polymerase chain reaction for severe acute respiratory syndrome coronavirus 2: role of deep-learning-based ct diagnosis and insights from two cases. Korean J. Radiol [cited 2020 19];21:505. https://synapse.koreamed.org/DOIx.php?id=10.3348/kjr.2020.0146

11.

Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, et al (2020) Detection of SARS-CoV-2 in different types of clinical specimens. JAMA [cited 2020 23] http://www.ncbi.nlm.nih.gov/pubmed/32159775. https://doi.org/10.1001/jama.2020.3786

12.

Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al (2020) Sensitivity of chest CT for COVID-19: comparison to RT-PCR. Radiology [cited 2020 26];200432. http://www.ncbi.nlm.nih.gov/pubmed/32073353. https://doi.org/10.1148/radiol.2020200432

13.

Long C, Xu H, Shen Q, Zhang X, Fan B, Wang C et al (2020) Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT? Eur J Radiol 1:126. https://doi.org/10.1016/j.ejrad.2020.108961CrossRef

14.

Spencer S, Thompson MG, Flannery B, Fry A (2019) Comparison of respiratory specimen collection methods for detection of influenza virus infection by reverse transcription-PCR: a literature review. J Clin Microbiol 57:1–6. https://doi.org/10.1128/JCM.00027-19CrossRef

15.

Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, et al (2020) SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med cited 2020 23];382:1177–9. http://www.nejm.org/doi/10.1056/NEJMc2001737. https://doi.org/10.1056/NEJMc2001737

16.

Huang Y, Chen S, Yang Z, Guan W, Liu D, Lin Z, et al (2020) SARS-CoV-2 Viral load in clinical samples of critically ill patients. Am J Respir Crit Care Med [cited 2020 26]. http://www.ncbi.nlm.nih.gov/pubmed/32293905. https://doi.org/10.1164/rccm.202003-0572LE

Title: The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?
Authors: Eric Farfour
Philippe Lesprit
Benoit Visseaux
Tiffany Pascreau
Emilie Jolly
Nadira Houhou
Laurence Mazaux
Marianne Asso-Bonnet
Marc Vasse
on behalf of the SARS-CoV-2 Foch Hospital study group
Publication date: 01-10-2020
Publisher: Springer Berlin Heidelberg
Keywords: SARS-CoV-2
COVID-19
Published in: European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2020
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-020-03930-8

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 10/2020

First report of Tsukamurella endocarditis in an immunocompromised patient receiving chemotherapy

Relationships among streptococci from the mitis group, misidentified as Streptococcus pneumoniae

Implementation of the eazyplex® CSF direct panel assay for rapid laboratory diagnosis of bacterial meningitis: 32-month experience at a tertiary care university hospital

Rapid identification of uropathogens by combining Alfred 60 system with matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry technology

Leprosy in the twenty-first century: a microbiological, clinical, and epidemiological study in northwestern Spain

Children account for a small proportion of diagnoses of SARS-CoV-2 infection and do not exhibit greater viral loads than adults

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage